How empathy affects outcomes in early-stage colon cancer
Part of Cancer, Digestive system clinical trials.
This study looks at whether how patients experience and express empathy during treatment is linked to better results after curative treatment for colon cancer that has not spread. You may be asked to complete questionnaires to help researchers understand what matters for recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You speak and read French well enough to answer questionnaires on your own
- You have non-metastatic, “uncomplicated” colorectal cancer (not involving blockage, perforation, or bleeding)
- Your cancer type is adenocarcinoma (not other colorectal cancer types)
- You live in the Calvados or Manche area and are covered by the French social security system
- You’re not pregnant and don’t have certain other ongoing cancers or specific bowel/genetic diseases
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how the immune system responds to colon cancer, especially when it has spread. Researchers want to understand and possibly boost immune reactions during surgery. It may help find better ways to treat colorectal cancer in the future.
This study looks at how gut bacteria (the microbiome) change during treatment for colorectal cancer that has spread or cannot be removed. Researchers hope the findings may help improve understanding of how treatment works and how to tailor care.
This study looks at how early-onset colorectal cancer treatment affects reproductive and sexual health over time. It asks eligible people to complete questionnaires so researchers can understand and possibly improve care during and after treatment.
This study tests a smartphone-based program that uses artificial intelligence to help colorectal cancer survivors better understand and manage their emotions, with the goal of improving resilience and quality of life after treatment. The program is designed specifically for cancer survivors who have finished their main treatment.
This trial tests whether training healthcare providers in empathetic communication improves their interactions with people receiving lung cancer care. You may be invited because your doctor’s clinic is participating and you meet the patient and language requirements.
This study tests if matching treatments to your tumor's genetic markers can help slow down metastatic colorectal cancer. You'll get a biopsy and blood draw to guide your therapy.
Hear when a new Non-metastatic Colorectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.